Filtered By:
Vaccination: Meningitis Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 126 results found since Jan 2013.

Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research

AAP Approves 2023 Child and Adolescent Immunization Schedule AAP Approves 2023 Child and Adolescent Immunization Schedule
Minor changes and additions to annual ACIP recommendations affected vaccines for COVID-19; dengue fever; pneumococcal disease; and measles, mumps, and rubella.Medscape Medical News
Source: Medscape Allergy Headlines - February 9, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

Pneumococcal Vaccine Lowers Hospitalization Risk for Elderly Pneumococcal Vaccine Lowers Hospitalization Risk for Elderly
Older adults who received the 13-valent pneumococcal conjugate vaccine were less likely to be hospitalized for pneumonia, a new study found.Medscape Medical News
Source: Medscape Allergy Headlines - December 6, 2022 Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news

Infant BCG Vaccine Protects Only Those Under Age 5 Years Infant BCG Vaccine Protects Only Those Under Age 5 Years
Although the BCG vaccine may keep severe forms of tuberculosis, meningitis, and miliary tuberculosis at bay, its efficacy and effectiveness against pulmonary tuberculosis are low.Medscape Medical News
Source: Medscape Allergy Headlines - December 5, 2022 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Pneumococcal Vaccine Uptake Remains Low in At-Risk Canadians Pneumococcal Vaccine Uptake Remains Low in At-Risk Canadians
Clinicians should encourage vaccination against pneumococcal disease as COVID-19 and flu cases rise, researchers say.Medscape Medical News
Source: Medscape Allergy Headlines - November 11, 2022 Category: Allergy & Immunology Tags: Public Health & Prevention News Source Type: news

From A to Y: Meningococcal Diseases and Vaccination From A to Y: Meningococcal Diseases and Vaccination
A vaccination campaign against meningococcal B bacteria has been initiated in the Chamb éry and Lyon-East regions of France following an increase in infections with a new variant.Medscape Medical News
Source: Medscape Allergy Headlines - November 11, 2022 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Specific antibody deficiency: Pearls and pitfalls for diagnosis
CONCLUSION: Clinical evaluations in individuals with self-reported recurrent acute sinusitis or lower respiratory infections need to document an infectious etiology with pyogenic bacteria and must rule out an underlying primary airway inflammatory disorder before consideration is made regarding the presence of an immune deficiency. In addition, decision making regarding diagnosis and treatment of patients being evaluated for humoral immunodeficiency should not hinge solely on the strict application of defined cutoffs for "normal" response to a single polysaccharide vaccine, but rather a global assessment of humoral immune ...
Source: Annals of Allergy, Asthma and Immunology - June 7, 2022 Category: Allergy & Immunology Authors: Monica G Lawrence Larry Borish Source Type: research

5 Things to Know About New Pneumococcal Vaccine Guidance 5 Things to Know About New Pneumococcal Vaccine Guidance
Adult pneumococcal vaccine recommendations have been considered some of the most complicated vaccine recommendations to appropriately implement. The good news: Implementation just got simpler.CDC Expert Commentary
Source: Medscape Allergy Headlines - February 17, 2022 Category: Allergy & Immunology Tags: Infectious Diseases Commentary Source Type: news

ACIP Issues Adult Vaccination Schedule 2022 ACIP Issues Adult Vaccination Schedule 2022
Changes affect zoster, pneumococcal, and hepatitis B vaccines, and COVID-19 is now included.News Alerts
Source: Medscape Allergy Headlines - February 17, 2022 Category: Allergy & Immunology Tags: Internal Medicine News Alert Source Type: news

Descriptive Study of IgG Protection for PCV13 Serotypes in Immunodeficient Patients on IVIG
Intravenous immunoglobulin (IVIG) therapy provides IgG antibodies from a donor pool to immunodeficient patients. Since PCV13 vaccine was introduced in 2010, adult donors may not have received the vaccine, thus not having PCV13 specific antibodies to donate. This descriptive analysis will highlight how pneumococcal vaccination affects Streptococcus pneumoniae protection, hospitalization rates, and associated comorbidities in immunodeficient individuals.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Ethan Kallenberger, Andrea D, Lynn Chollet-Hinton, Marissa Love Source Type: research

Pneumococcal Vaccinations In Young Adults With HIV
CDC guidelines recommend pneumococcal conjugate vaccine (PCV) followed by polysaccharide vaccine (PPSV23) for adult HIV+ patients. This assumes immune compromise. Most young adults with HIV have received PCV as infants.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Jahanzeb Javed, Elizabeth Secord, Eric McGrath Source Type: research

Health ‐care utilization for sinusitis after pneumococcal vaccination in patients with low antibody titers
ConclusionMost patients with CRS and RARS have nonprotective antibody titers. PPSV23 administration significantly decreases health-care utilization.
Source: International Forum of Allergy and Rhinology - January 10, 2022 Category: Allergy & Immunology Authors: Anna K. Bareiss, Nrusheel Kattar, Rick Tivis, Graham Unis, Triet Do, Lawrence Montelibano, Eboni G. Price ‐Haywood, Edward McCoul Tags: ORIGINAL ARTICLE Source Type: research

Healthcare utilization for sinusitis after pneumococcal vaccination in patients with low antibody titers
CONCLUSIONSMost patients with CRS and RARS have non-protective antibody titers. PPSV23 administration significantly decreases healthcare utilization.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - December 28, 2021 Category: Allergy & Immunology Authors: Anna K. Bareiss, Nrusheel Kattar, Rick Tivis, Graham Unis, Triet Do, Lawrence Montelibano, Eboni G. Price ‐Haywood, Edward McCoul Tags: ORIGINAL ARTICLE Source Type: research